PAR2 in Immuno-oncology: From Target Identification to the Selection of a Candidate with a Superior Mode of Action
Time: 9:00 am
day: Conference Day Two
Details:
- Target identification through public and proprietary clinical data
- Target validation with relevant in vivo models
- Understanding of receptor biology and thorough benchmark to determine the optimal mechanism of action
